Word count: 3000 words
Objectives to cover:
- Introduction – Stroke is a major cause of mortality and disability worldwide. Early assessment of disease severity and prognosis is essential for timely management and improved patient outcomes.
- Serum Ferritin – Serum ferritin is an acute-phase reactant and indicator of body iron stores that may reflect inflammation and oxidative stress in acute stroke.
- Study Population – Patients diagnosed with acute ischemic or hemorrhagic stroke are included based on predefined inclusion and exclusion criteria.
- Data Collection – Clinical history, demographic details, laboratory investigations, and serum ferritin levels are recorded at the time of admission.
- Severity Assessment – Stroke severity is evaluated using standardized neurological assessment scales such as the National Institutes of Health Stroke Scale (NIHSS).
- Prognostic Assessment – Clinical outcomes and functional status are assessed using validated measures such as the Modified Rankin Scale (mRS) at discharge or follow-up.
- Statistical Analysis – The relationship between serum ferritin levels, stroke severity, and patient outcomes is analyzed using appropriate statistical methods.
- Result Discussion – The findings highlight the association between elevated serum ferritin levels and increased stroke severity, poor functional outcome, and overall prognosis.
- Conclusion – Serum ferritin may serve as a valuable biomarker for assessing stroke severity and predicting prognosis, supporting early risk stratification and clinical decision-making.
Reference: Harvard style